← Open Payments lookup

ALESSANDRA FITZPATRICK: Open Payments

NPI 1346749900 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 30 payments from 17 companies in 2025. Trend: 2023 $332 · 2024 $468 · 2025 $781

Food & beverage: $681Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.2$120
Novartis Pharmaceuticals Corporation5$115
ABBVIE INC.4$107
GlaxoSmithKline, LLC.2$66
Merck Sharp & Dohme LLC2$48
Alnylam Pharmaceuticals Inc.3$48
PFIZER INC.2$44
PharmaEssentia USA Corporation1$33
Daiichi Sankyo Inc.1$28
Genentech USA, Inc.1$25

Products named: ERLEADA, SCEMBLIX, EPKINLY, OJJAARA, BESREMI, BLENREP, IMBRUVICA, AMVUTTRA.

Industry payments across MD — which companies pay providers there.